Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Centene
CNC
$32.9B
| $101M | 0.09% |
2,341,632
+1,861,900
| +388% | +$90.7M |
|
277
FirstService
FSV
$6.18B
| $101M | 0.09% |
986,593
+44,000
| +5% | +$4.48M |
|
278
CorVel
CRVL
$3.07B
| $101M | 0.09% |
3,997,830
-70,800
| -2% | -$2.01M |
|
279
Delta Air Lines
DAL
$58.6B
| $100M | 0.08% |
1,741,800
+1,559,000
| +853% | +$92.3M |
|
280
Avis
CAR
$4.82B
| $100M | 0.08% |
3,540,400
+103,700
| +3% | +$3.18M |
|
281
Brookdale Senior Living
BKD
$3.07B
| $98.5M | 0.08% |
12,990,325
+1,605,630
| +14% | +$12.7M |
|
282
Qualcomm
QCOM
$170B
| $98.4M | 0.08% |
+1,290,400
| New | +$97.1M |
|
283
Commault Systems
CVLT
$5.76B
| $98.4M | 0.08% |
2,200,387
+334,100
| +18% | +$15.3M |
|
284
Logitech
LOGI
$14.6B
| $97.8M | 0.08% |
2,399,500
-75,500
| -3% | -$3.03M |
|
285
Morningstar
MORN
$7.27B
| $97.3M | 0.08% |
665,870
+22,100
| +3% | +$3.4M |
|
286
Omega Healthcare
OHI
$13.9B
| $96.7M | 0.08% |
2,312,778
+525,600
| +29% | +$20.5M |
|
287
US Foods
USFD
$23.4B
| $96.6M | 0.08% |
2,350,905
+1,334,605
| +131% | +$51.5M |
|
288
Teradata
TDC
$2.49B
| $96.5M | 0.08% |
3,111,800
-780,900
| -20% | -$26.3M |
|
|
KL
289
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $95.8M | 0.08% |
2,138,893
-141,807
| -6% | -$6.47M |
|
|
CCMP
290
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $95.7M | 0.08% |
677,439
-248,827
| -27% | -$30.7M |
|
291
Alkermes
ALKS
$8.28B
| $95.6M | 0.08% |
4,901,208
+950,622
| +24% | +$20.7M |
|
292
Medifast
MED
$130M
| $95.6M | 0.08% |
922,615
+232,300
| +34% | +$25M |
|
|
MLNX
293
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $95.6M | 0.08% |
871,983
-349,400
| -29% | -$38.6M |
|
294
Brown & Brown
BRO
$23.4B
| $95.3M | 0.08% |
2,643,200
-1,006,900
| -28% | -$36M |
|
295
Salesforce
CRM
$158B
| $94.5M | 0.08% |
636,481
+160,162
| +34% | +$24.3M |
|
296
Cardinal Health
CAH
$55.1B
| $94.1M | 0.08% |
1,994,720
+362,800
| +22% | +$16.6M |
|
297
Burlington
BURL
$22.2B
| $94M | 0.08% |
+470,527
| New | +$86.5M |
|
|
SJR
298
DELISTED
Shaw Communications Inc.
SJR
| $93.1M | 0.08% |
4,735,400
+980,400
| +26% | +$19.3M |
|
299
Telephone and Data Systems
TDS
$3.88B
| $93.1M | 0.08% |
3,607,192
-197,600
| -5% | -$5.51M |
|
300
CVR Energy
CVI
$3.45B
| $92.7M | 0.08% |
2,104,769
+289,128
| +16% | +$13.5M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.